Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
MEDI0562 for Head and Neck Cancer and Melanoma
Recruiting1 awardPhase 1
Portland, Oregon
This trial will see if it's safe to use MEDI0562, a humanized OX40 agonist, before surgery for people with head and neck squamous cell carcinoma or melanoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service